Total plasma MVs and sub‐populations positive for CEA, A33, LGR5, EPHB2, ICAM‐1, CD31, CD42a, CD31+/CD42a‐ (Figure 1) were significantly higher in patients diagnosed with BCRP and CRC in comparison to healthy controls (Table 2). This evidence concerns the gene GP9 and colorectal carcinoma.